Lower-middle income (World Bank) vs New Zealand: Treatment success rate for patients treated for MDR-TB
Lower-middle income (World Bank)
76.0%
in 2022
New Zealand
100.0%
in 2022
Lower-middle income (World Bank) rank
3rd
New Zealand rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Lower-middle income (World Bank)
- New Zealand
How they compare
New Zealand currently reports 100.0% against 76.0% in Lower-middle income (World Bank), a difference of 24.0%.
That makes New Zealand's figure about 1.3 times Lower-middle income (World Bank)'s.
The two have swapped places 6 times across 17 shared years of data; in 2002 it was New Zealand ahead.
Lower-middle income (World Bank) ranks 3rd and New Zealand ranks 1st of 11 groups.
Across the 3 decades both report, Lower-middle income (World Bank) averaged higher in 1 and New Zealand in 2.
Head to head by decade
| Decade | Lower-middle income (World Bank) | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.2% | 48.2% | 4.0% | Lower-middle income (World Bank) |
| 2010s | 55.5% | 66.6% | 11.1% | New Zealand |
| 2020s | 73.7% | 100.0% | 26.3% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Lower-middle income (World Bank) or New Zealand?
- New Zealand, at 100.0% against 76.0% in Lower-middle income (World Bank) as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Lower-middle income (World Bank) and New Zealand?
- 24.0%, with New Zealand ahead.
- How many years of comparable data are there for Lower-middle income (World Bank) and New Zealand?
- 17 years are reported by both, from 2002 to 2022.
- How do Lower-middle income (World Bank) and New Zealand rank globally for treatment success rate for patients treated for mdr-tb?
- Lower-middle income (World Bank) ranks 3rd and New Zealand ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.